How Drug Companies Slow Generic Competition
AARP reports that list prices for 25 widely used Medicare drugs have risen since their market launches. These increases add to Medicare prescription-drug spending under both Part B and Part D.
Source: AARP ·
Grace's Take
Drugs that should be getting cheaper aren't—and that gap between what *should* happen and what *is* happening could eat into your healthcare budget for the next 30 years. If you're a decade from retirement, prescription costs are still a blurry line item in your planning. But Medicare Part D premiums and out-of-pocket drug costs become a meaningful portion of monthly income once you stop working, especially if you're managing chronic conditions common in your 60s and 70s. Worth checking whether your long-term care insurance estimates or healthcare retirement projections assume generic pricing, or if they've built in room for sustained brand-name costs.
- •Prices for 25 major Medicare drugs have increased since launch.
- •Higher list prices contribute to Medicare Part B and Part D spending.
- •Limited generic competition can keep prescription costs elevated.
People in or approaching retirement may face continued pressure from prescription costs and should compare formularies, alternatives, and available assistance programs.